Combination therapy of infliximab and azathioprine reduces disease progression in Crohn's disease

Inflamm Bowel Dis. 2008 Jan;14(1):143-5. doi: 10.1002/ibd.20260.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antibodies, Monoclonal / therapeutic use*
  • Azathioprine / therapeutic use*
  • Crohn Disease / drug therapy*
  • Drug Therapy, Combination
  • Female
  • Humans
  • Infliximab
  • Male
  • Middle Aged
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Infliximab
  • Azathioprine